IL1B and diabetic kidney disease: Recent studies have demonstrated the prominent role of inflammatory mechanisms, specifically the cytokine interleukin-1β (IL-1β) and the NLRP3 inflammasome, in promoting DKD (Navarro-González et al., 2011).